PMID- 21861964
OWN - NLM
STAT- MEDLINE
DCOM- 20120117
LR  - 20231012
IS  - 1097-6868 (Electronic)
IS  - 0002-9378 (Print)
IS  - 0002-9378 (Linking)
VI  - 205
IP  - 5
DP  - 2011 Nov
TI  - Adverse events following administration to pregnant women of influenza A (H1N1) 
      2009 monovalent vaccine reported to the Vaccine Adverse Event Reporting System.
PG  - 473.e1-9
LID - 10.1016/j.ajog.2011.06.047 [doi]
AB  - OBJECTIVE: The objective of the study was to evaluate and summarize reports to 
      the Vaccine Adverse Event Reporting System (VAERS), a spontaneous reporting 
      system, in pregnant women who received influenza A (H1N1) 2009 monovalent vaccine 
      to assess for potential vaccine safety problems. STUDY DESIGN: We reviewed 
      reports of adverse events (AEs) in pregnant women who received 2009-H1N1 vaccines 
      from Oct. 1, 2009, through Feb. 28, 2010. RESULTS: VAERS received 294 reports of 
      AEs in pregnant women who received 2009-H1N1 vaccine: 288 after inactivated and 6 
      after the live attenuated vaccines. Two maternal deaths were reported. Fifty-nine 
      women (20.1%) were hospitalized. We verified 131 pregnancy-specific outcomes: 95 
      spontaneous abortions (<20 weeks); 18 stillbirths (>/=20 weeks); 7 preterm 
      deliveries (<37 weeks); 3 threatened abortions; 2 preterm labor; 2 preeclampsia; 
      and 1 each of fetal hydronephrosis, fetal tachycardia, intrauterine growth 
      retardation, and cleft lip. CONCLUSION: Review of reports to VAERS following H1N1 
      vaccination in pregnant women did not identify any concerning patterns of 
      maternal or fetal outcomes.
CI  - Published by Mosby, Inc.
FAU - Moro, Pedro L
AU  - Moro PL
AD  - Immunization Safety Office, Division of Healthcare Quality Promotion, National 
      Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control 
      and Prevention, Atlanta, GA, USA. pmoro@cdc.gov
FAU - Broder, Karen
AU  - Broder K
FAU - Zheteyeva, Yenlik
AU  - Zheteyeva Y
FAU - Revzina, Natalya
AU  - Revzina N
FAU - Tepper, Naomi
AU  - Tepper N
FAU - Kissin, Dmitry
AU  - Kissin D
FAU - Barash, Faith
AU  - Barash F
FAU - Arana, Jorge
AU  - Arana J
FAU - Brantley, Mary D
AU  - Brantley MD
FAU - Ding, Helen
AU  - Ding H
FAU - Singleton, James A
AU  - Singleton JA
FAU - Walton, Kimp
AU  - Walton K
FAU - Haber, Penina
AU  - Haber P
FAU - Lewis, Paige
AU  - Lewis P
FAU - Yue, Xin
AU  - Yue X
FAU - Destefano, Frank
AU  - Destefano F
FAU - Vellozzi, Claudia
AU  - Vellozzi C
LA  - eng
GR  - CC999999/Intramural CDC HHS/United States
PT  - Journal Article
DEP - 20110621
PL  - United States
TA  - Am J Obstet Gynecol
JT  - American journal of obstetrics and gynecology
JID - 0370476
RN  - 0 (Influenza Vaccines)
RN  - 0 (Vaccines, Attenuated)
SB  - IM
MH  - Adverse Drug Reaction Reporting Systems
MH  - Female
MH  - Humans
MH  - Influenza A Virus, H1N1 Subtype/*immunology
MH  - Influenza Vaccines/*adverse effects
MH  - Influenza, Human/immunology/*prevention & control
MH  - Patient Safety
MH  - Pregnancy
MH  - Vaccines, Attenuated/adverse effects
PMC - PMC6602056
MID - NIHMS1025602
EDAT- 2011/08/25 06:00
MHDA- 2012/01/18 06:00
PMCR- 2019/07/01
CRDT- 2011/08/25 06:00
PHST- 2010/12/03 00:00 [received]
PHST- 2011/04/11 00:00 [revised]
PHST- 2011/06/09 00:00 [accepted]
PHST- 2011/08/25 06:00 [entrez]
PHST- 2011/08/25 06:00 [pubmed]
PHST- 2012/01/18 06:00 [medline]
PHST- 2019/07/01 00:00 [pmc-release]
AID - S0002-9378(11)00775-7 [pii]
AID - 10.1016/j.ajog.2011.06.047 [doi]
PST - ppublish
SO  - Am J Obstet Gynecol. 2011 Nov;205(5):473.e1-9. doi: 10.1016/j.ajog.2011.06.047. 
      Epub 2011 Jun 21.